Bupa shift towards digital could impact M&A By Dr Leonid Shapiro
https://www.healthcarebusinessinternational.com/bupa-targets-digital-strategy-amid-speculation-about-disposals/

Candesic's Dr Leonid Shapiro has commented on the Bupa's M&A strategy in the HBI Intelligence. 

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

Privacy

Privacy Policy

News & Publications

Candesic proudly advised on Kester Capital investment
Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist in market access consulting services to the pharmaceutical and biotech sectors. The mission of MAP Patient Access Limited is to make it easier for patients to access ground-breaking medicines, devices, and diagnostics. In addition to its expertise in rare and orphan diseases, it has a proven track record of helping its clients navigate increasingly complex healthcare reimbursement pathways.

HealthTechX Global 2023 was quite the event!
Thanks to all HealthTechX Global 2023- it was quite the event!

Candesic visits Imperial College Business School ‎
This week our team visited Imperial College Business School. **Candesic** is a leading strategy consultancy providing CEO level clarity with R&D level insights for over 21 years.

© Candesic 2023